RTI Biologics Announces Milestone in Tissue Processing: More than 5 Million Implants Sterilized With Zero Incidence of Implant-Associated Infection

Published: May 24, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ALACHUA, Fla.--(BUSINESS WIRE)--RTI Biologics Inc. (RTI) (Nasdaq:RTIX), a leading provider of orthopedic and other biologic implants, is pleased to announce that the company has passed the five million mark in distributing implants sterilized through its patented, validated tissue sterilization processes, BioCleanse®, Tutoplast® and Cancelle® SP, with zero incidence of implant-associated infection.

Help employers find you! Check out all the jobs and post your resume.

Back to news